These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9774954)

  • 1. Role of taxanes in lung-cancer chemotherapy.
    Schiller JH
    Cancer Invest; 1998; 16(7):471-7. PubMed ID: 9774954
    [No Abstract]   [Full Text] [Related]  

  • 2. The development of docetaxel (Taxotere) in non-small cell lung cancer.
    Kris MG; Miller VA; Ng KK; Grant SC
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-1-S14-4. PubMed ID: 9335515
    [No Abstract]   [Full Text] [Related]  

  • 3. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: an international update.
    Kris MG; Manegold C
    Semin Oncol; 2001 Feb; 28(1 Suppl 2):1-3. PubMed ID: 11284618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Second-line and beyond: Docetaxel in the treatment of non-small-cell lung cancer].
    Rinaldi M
    Tumori; 2001; 87(6):A6-9. PubMed ID: 11995708
    [No Abstract]   [Full Text] [Related]  

  • 5. [Docetaxel (taxotere) in non-small-cell bronchial carcinoma].
    Manegold C
    Med Klin (Munich); 1997 Sep; 92 Suppl 4():10-5. PubMed ID: 9446014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Taxotere in various solid tumors].
    Orel NF
    Vopr Onkol; 1998; 44(5):639-44. PubMed ID: 9925501
    [No Abstract]   [Full Text] [Related]  

  • 7. Docetaxel as second-line chemotherapy for non-small-cell lung cancer.
    Roila F; Del Favero A; Ballatori E
    J Clin Oncol; 2000 Nov; 18(21):3738-9. PubMed ID: 11054450
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II study of docetaxel (taxotere) in patients with previously untreated extensive small cell lung cancer.
    Latreille J; Cormier Y; Martins H; Goss G; Fisher B; Eisenhauer EA
    Invest New Drugs; 1996; 13(4):343-5. PubMed ID: 8824354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding horizons: an update on the use of docetaxel in non-small cell lung, ovarian, and breast cancers.
    Hortobagyi GN; Kris MG
    Semin Oncol; 2002 Jun; 29(3 Suppl 12):1-3. PubMed ID: 12170444
    [No Abstract]   [Full Text] [Related]  

  • 10. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer.
    Kris MG; Millward M
    Semin Oncol; 1999 Jun; 26(3 Suppl 10):1-2. PubMed ID: 10437742
    [No Abstract]   [Full Text] [Related]  

  • 11. Docetaxel and radiation as combined-modality therapy.
    Kim ES; Khuri FR
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):97-105. PubMed ID: 12108904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel: current status and future prospects.
    Eisenhauer E
    J Clin Oncol; 1995 Dec; 13(12):2865-8. PubMed ID: 8523048
    [No Abstract]   [Full Text] [Related]  

  • 13. [Early phase II clinical study of RP56976 (docetaxel) in patients with primary pulmonary cancer. Docetaxel Cooperative Study Group for Lung Cancer].
    Yokoyama A; Kurita Y; Watanabe K; Negoro S; Ogura T; Nakano M; Minoda S; Niitani H; Taguchi T
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2609-16. PubMed ID: 7979421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced non-small cell lung carcinoma: the emerging role of docetaxel.
    Langer CJ
    Invest New Drugs; 2000 Feb; 18(1):17-28. PubMed ID: 10830138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel (Taxol) and docetaxel (Taxotere): active chemotherapeutic agents in lung cancer.
    Francis PA; Kris MG; Rigas JR; Grant SC; Miller VA
    Lung Cancer; 1995 Apr; 12 Suppl 1():S163-72. PubMed ID: 7551925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of docetaxel (Taxotere) in the treatment of non-small cell lung cancer.
    Fossella FV
    Semin Oncol; 1999 Jun; 26(3 Suppl 11):4-8. PubMed ID: 10458203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel (Taxotere) as a single agent and in combination chemotherapy for the treatment of patients with advanced non-small cell lung cancer.
    Miller VA; Kris MG
    Semin Oncol; 2000 Apr; 27(2 Suppl 3):3-10. PubMed ID: 10810932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The taxanes: an update.
    Crown J; O'Leary M
    Lancet; 2000 Apr; 355(9210):1176-8. PubMed ID: 10791395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New anti-tubulin agents.
    Felip E
    Suppl Tumori; 2002; 1(4):S17-8. PubMed ID: 12415808
    [No Abstract]   [Full Text] [Related]  

  • 20. Docetaxel in the management of advanced non-small cell lung cancer.
    Miller VA
    Semin Oncol; 1998 Jun; 25(3 Suppl 8):15-9. PubMed ID: 9704671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.